Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models.

MLA

McClure, Mark E., et al. “Long-Term Maintenance Rituximab for ANCA-Associated Vasculitis: Relapse and Infection Prediction Models.” Rheumatology (Oxford, England), vol. 60, no. 3, Mar. 2021, pp. 1491–501. EBSCOhost, https://doi.org/10.1093/rheumatology/keaa541.

APA

McClure, M. E., Zhu, Y., Smith, R. M., Gopaluni, S., Tieu, J., Pope, T., Kristensen, K. E., Jayne, D. R. W., Barrett, J., & Jones, R. B. (2021). Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models. Rheumatology (Oxford, England), 60(3), 1491–1501. https://doi.org/10.1093/rheumatology/keaa541

Chicago

McClure, Mark E, Yajing Zhu, Rona M Smith, Seerapani Gopaluni, Joanna Tieu, Tasneem Pope, Karl Emil Kristensen, David R W Jayne, Jessica Barrett, and Rachel B Jones. 2021. “Long-Term Maintenance Rituximab for ANCA-Associated Vasculitis: Relapse and Infection Prediction Models.” Rheumatology (Oxford, England) 60 (3): 1491–1501. doi:10.1093/rheumatology/keaa541.